
nyra health (Formerly myReha)
MyReha was founded with the idea of using the possibilities of digitization to overcome the limits of today's therapy, to expand therapy content and to enable you to get the most out of your therapy.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor | €0.0 | round | |
* | €4.5m | Seed | |
Total Funding | 000k |
EUR | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | (60 %) | 155 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
nyra health is an Austrian-based software company that has developed a digital therapy platform for neurological rehabilitation. The company's main offering is the myReha app, a CE-certified medical device that provides individualized therapy plans for patients with speech and cognitive impairments. The app is designed for use in clinical settings and at home, and it is complemented by the nyra insights web platform, which offers analytics and patient orchestration for therapists and clinics.
nyra health operates on a B2B and SaaS business model, targeting healthcare facilities and therapists. The company's solutions aim to improve the efficiency and effectiveness of neurological therapy by leveraging AI-powered technology to create personalized and adaptive treatment plans. The platform supports a multimodal approach to therapy, adapting to the specific needs of each patient.
Keywords: digital therapy, neurological rehabilitation, medical device, SaaS, B2B, healthtech, AI-powered therapy, speech therapy, cognitive rehabilitation, patient analytics